Search Results - "Petschulies, Marco"

Ten years of AMNOG from an oncological perspective: new horizons and continuing expansion by Bartol, Arne, Dressler, Katrin, Kaskel, Peter, Landsberg, Christiane, Lechner, Cornelia, Petschulies, Marco

“…Purpose 2021 marks the tenth anniversary of the AMNOG process and brought with it a new German administration—two good reasons to take stock of where we stand…”
Get full text

Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of fruquintinib + best supportive care (BSC) compared with placebo + BSC in metastatic colorectal cancer (mCRC): Results from the FRESCO-2 trial by Stintzing, Sebastian, Tabernero, Josep, Satoh, Taroh, Dasari, Arvind, Lonardi, Sara, Eng, Cathy, Garcia-Carbonero, Rocio, Elez, Elena, Yoshino, Takayuki, Sobrero, Alberto F., Yao, James C., Kasper, Stefan, Arnold, Dirk, Basic, Edin, Granold, Matthias, Petschulies, Marco, Wu, Liwen, Chen, Lucy, Yang, Zhao, Van Cutsem, Eric

“…116 Background: As mCRC and its treatment can adversely impact quality of life (QoL), maintaining QoL is an important treatment goal in addition to improving…”
Get full text

Zehn Jahre AMNOG-Prozess aus Sicht der Onkologie: Neuland erschlossen, Bebauung geht weiter by Bartol, Arne, Dreßler, Katrin, Kaskel, Peter, Landsberg, Christiane, Lechner, Cornelia, Petschulies, Marco

Get full text

The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations by Tafuri, Giovanni, Lucas, Inês, Estevão, Steve, Moseley, Jane, d'Andon, Anne, Bruehl, Hannah, Gajraj, Elangovan, Garcia, Sonia, Hedberg, Niklas, Massari, Marco, Molina, Andrea, Obach, Mercè, Osipenko, Leeza, Petavy, Frank, Petschulies, Marco, Pontes, Caridad, Russo, Pierluigi, Schiel, Anja, Van de Casteele, Marc, Zebedin‐Brandl, Eva‐Maria, Rasi, Guido, Vamvakas, Spiros

“…Aims The parallel regulatory–health technology assessment scientific advice (PSA) procedure allows manufacturers to receive simultaneous feedback from both EU…”
Get full text

Innovation durch Kombination: Wie das GKV-Finanzstabilisierungsgesetz den therapeutischen Fortschritt ausbremst by Bartol, Arne, Dreßler, Katrin, Isbary, Georg, Lechner, Cornelia, Niemann, Ina, Petschulies, Marco

Get full text

Zehn Jahre AMNOG-Prozess aus Sicht der Onkologie: Neuland erschlossen, Bebauung geht weiter by Bartol, Arne, Dreßler, Katrin, Kaskel, Peter, Landsberg, Christiane, Lechner, Cornelia, Petschulies, Marco

Get full text